StockData
Biomerica Inc logo

Biomerica Inc (BMRA) stock

BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3055% below fair value
$1.09−0.15 (-11.74%)

Close on Nov 18, 2026Market cap $5.01MP/E –Yield –

Biomerica operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Biomerica's operating cash flow for the twelve months ending Aug 31, 2026 was -$3.96M. For fiscal 2026 it was -$3.42M. The highest annual figure on record is $1.39M in fiscal 2013.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026May 31, 2026-$3.42M–
FY2025May 31, 2025-$3.84M–
FY2024May 31, 2024-$5.36M–
FY2023May 31, 2023-$5.47M–
FY2022May 31, 2022-$479.00K–
FY2021May 31, 2021-$5.25M–
FY2020May 31, 2020-$4.30M–
FY2019May 31, 2019-$2.24M–
FY2018May 31, 2018-$1.17M–
FY2017May 31, 2017-$722.86K–
FY2016May 31, 2016-$208.78K–
FY2015May 31, 2015-$405.48K–
FY2014May 31, 2014-$862.27K-161.9%
FY2013May 31, 2013$1.39M+845.7%
FY2012May 31, 2012$147.41K-55.2%
FY2011May 31, 2011$328.80K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Aug 31, 2026-$802.00K–
Q4 FY2026CQ2 2026May 31, 2026-$912.00K–
Q3 FY2026CQ1 2026Feb 28, 2026-$1.25M–
Q2 FY2026CQ4 2025Nov 30, 2025-$991.00K–
Q1 FY2026CQ3 2025Aug 31, 2025-$268.00K–
Q4 FY2025CQ2 2025May 31, 2025-$662.00K–
Q3 FY2025CQ1 2025Feb 28, 2025-$1.05M–
Q2 FY2025CQ4 2024Nov 30, 2024-$791.00K–
Q1 FY2025CQ3 2024Aug 31, 2024-$1.34M–
Q4 FY2024CQ2 2024May 31, 2024-$1.04M–
Q3 FY2024CQ1 2024Feb 29, 2024-$1.80M–
Q2 FY2024CQ4 2023Nov 30, 2023-$842.00K–
Q1 FY2024CQ3 2023Aug 31, 2023-$1.67M–
Q4 FY2023CQ2 2023May 31, 2023-$963.00K–
Q3 FY2023CQ1 2023Feb 28, 2023-$1.73M-173.1%
Q2 FY2023CQ4 2022Nov 30, 2022-$1.21M-190.3%
Q1 FY2023CQ3 2022Aug 31, 2022-$1.57M-2174.2%
Q4 FY2022CQ2 2022May 31, 2022-$4.26M–
Q3 FY2022CQ1 2022Feb 28, 2022$2.36M–
Q2 FY2022CQ4 2021Nov 30, 2021$1.34M–
Q1 FY2022CQ3 2021Aug 31, 2021$75.84K–
Q4 FY2021CQ2 2021May 31, 2021-$1.01M–
Q3 FY2021CQ1 2021Feb 28, 2021-$1.36M–
Q2 FY2021CQ4 2020Nov 30, 2020-$1.28M–
Q1 FY2021CQ3 2020Aug 31, 2020-$1.60M–
Q4 FY2020CQ2 2020May 31, 2020-$3.49M–
Q3 FY2020CQ1 2020Feb 29, 2020-$436.92K–
Q2 FY2020CQ4 2019Nov 30, 2019-$357.84K–
Q1 FY2020CQ3 2019Aug 31, 2019-$8.15K–
Q4 FY2019CQ2 2019May 31, 2019-$986.33K–
Q3 FY2019CQ1 2019Feb 28, 2019-$256.64K–
Q2 FY2019CQ4 2018Nov 30, 2018-$244.41K–
Q1 FY2019CQ3 2018Aug 31, 2018-$756.66K–
Q4 FY2018CQ2 2018May 31, 2018-$322.05K–
Q3 FY2018CQ1 2018Feb 28, 2018-$488.82K–
Q2 FY2018CQ4 2017Nov 30, 2017-$238.64K–
Q1 FY2018CQ3 2017Aug 31, 2017-$124.71K–
Q4 FY2017CQ2 2017May 31, 2017-$333.48K–
Q3 FY2017CQ1 2017Feb 28, 2017-$81.49K–
Q2 FY2017CQ4 2016Nov 30, 2016-$235.96K–

More Biomerica figures

See a number that looks wrong?